600 mg, prolonged-release hard capsules
Potassium Chloride
Kaldyum is used for the prevention and treatment of potassium deficiency in the body. The deficiency may be caused by taking certain medications, such as diuretics (water pills), or by certain diseases (e.g., gastrointestinal diseases with vomiting or diarrhea).
Before starting to take Kaldyum, discuss it with your doctor or pharmacist.
Before prescribing the medicine, the doctor may check the potassium level in the blood and perform an EKG.
Inform your doctor about any ulcers or other gastrointestinal diseases.
If you are taking digitalis glycosides (medicines used for heart conditions), inform your doctor, as sudden discontinuation of Kaldyum may be harmful.
In some cases, the doctor may prescribe another potassium-containing medicine, while in other cases, they may recommend taking an additional medicine with Kaldyum.
Follow the diet prescribed by your doctor.
Tell your doctor or pharmacist about all the medicines you are taking or have recently taken, as well as any medicines you plan to take.
Be cautious when taking Kaldyum with the following medicines:
If you have any doubts about the medicines you are taking, consult your doctor.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Kaldyum can be used during pregnancy and breastfeeding, in accordance with the indications and recommended dosage.
There are no restrictions.
Always take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
The doctor will determine the dosage based on the individual needs of the patient.
Prophylaxis: the recommended dose is 2 or 3 capsules per day.
Treatment: the recommended dose is 5 to 12 capsules per day, with regular monitoring of potassium levels in the blood.
If the daily dose exceeds 2 capsules, it should be divided into two or more doses.
Usually, the capsule should be swallowed whole, with a glass of water, during or after a meal.
If the patient is being fed through a gastric or intestinal tube, the capsule can be opened and the pellets mixed with food or liquid administered through the tube.
Experience with the use of Kaldyum in children is limited.
In severe kidney failure, the use of Kaldyum is contraindicated (see "When not to take Kaldyum").
No studies have been conducted in patients with liver failure.
Due to possible decreased kidney function in elderly patients, a dose reduction may be necessary.
If you have taken more than the recommended dose of Kaldyum, consult your doctor or pharmacist immediately.
Overdose symptoms: muscle weakness, decreased blood pressure, arrhythmias, and even cardiac arrest.
Treatment: gastric lavage, infusion of sodium chloride, glucose, and insulin, and forced diuresis may be used. Dialysis (peritoneal or hemodialysis) may be necessary.
Do not take a double dose to make up for a missed dose.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Kaldyum can cause side effects, although not everybody gets them.
Stop taking the medicine and consult your doctor immediately if you experience any of the following symptoms:
Other side effects:
If you experience any side effects, including any side effects not listed in the leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, National Institute of Pharmacy and Nutrition, Alkotmány u. 3-5, 1054 Budapest, Hungary, phone: +36 1 472-8154, fax: +36 1 472-8155, website: https://www.ogyei.gov.hu.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 25°C.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance of Kaldyum is potassium chloride.
Each prolonged-release hard capsule contains 600 mg of potassium chloride, equivalent to 8 mmol of potassium ions (315 mg of potassium ions).
microcrystalline cellulose, hypromellose, dimethicone, talc, colloidal anhydrous silica, indigo carmine (E 132)
Capsule shell:
cap: gelatin, indigo carmine (E 132), erythrosine (E 127).
body: gelatin.
Kaldyum is a hard capsule with a blue cap and a transparent body.
The capsule contains a mixture of light blue and white or almost white pellets.
The packaging is a glass bottle with a polyethylene cap, in a cardboard box.
Pack size: 50 or 100 capsules (1 bottle of 100 capsules or 2 bottles of 50 capsules).
For more detailed information, consult the marketing authorization holder or parallel importer.
Egis Gyógyszergyár Zrt.
Keresztúri út 30-38.
H-1106 Budapest
Hungary
Egis Gyógyszergyár Zrt.
Mátyás király u. 65.
H-9900 Körmend
Hungary
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
License number in Hungary, the country of export: OGYI-T-5297/01
OGYI-T-5297/02
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.